We now have Quarter 4 H1B visa FY 2023 data and Quarter 4 PERM visa FY 2023 data and Quarter 4 H2A visa FY 2023 data.
Employer Search tool is moved to it's own page: "H1B Visa Data Search Tool"

Statistics and Summary

Perl Greg has been assisting clients through the H1B Visa process since 2016.

As of 2022, Perl Greg has succesfully submitted and recieved certification for 45 cases.

Perl Greg is located in New York, NY, and has represented 14 employers for the H1B Visa Process

47
Cases Handled
45
Cases Certified
95.74%
Approval

Cases Handled by Perl Greg

Case Number Case Status Job Title Industry Name Employer Name Year
I-200-18110-838184 CERTIFIED Computer Science Teachers Postsecondary Colleges Universities And Professional Schools St Josephs College 2018
I-200-18100-452543 CERTIFIED Computer Science Teachers Postsecondary Colleges Universities And Professional Schools St Josephs College 2018
I-200-15268-920757 CERTIFIED Computer Science Teachers Postsecondary All Other Professional Scientific And Technical Services St Josephs College 2016
I-200-18345-871294 CERTIFIED Medical Scientists Except Epidemiologists Pharmaceutical And Medicine Manufacturing Karyopharm Therapeutics Inc 2019
I-200-18289-487628 CERTIFIED Medical Scientists Except Epidemiologists Pharmaceutical And Medicine Manufacturing Karyopharm Therapeutics Inc 2019
I-200-18207-357012 CERTIFIED Medical Scientists Except Epidemiologists Pharmaceutical And Medicine Manufacturing Karyopharm Therapeutics Inc 2018
I-200-18066-504198 CERTIFIED Medical Scientists Except Epidemiologists Pharmaceutical And Medicine Manufacturing Karyopharm Therapeutics Inc 2018
I-200-18061-832355 CERTIFIED Medical Scientists Except Epidemiologists Pharmaceutical And Medicine Manufacturing Karyopharm Therapeutics Inc 2018
I-200-18061-552483 CERTIFIED Medical Scientists Except Epidemiologists Pharmaceutical And Medicine Manufacturing Karyopharm Therapeutics Inc 2018
I-200-18061-341250 CERTIFIED Medical Scientists Except Epidemiologists Pharmaceutical And Medicine Manufacturing Karyopharm Therapeutics Inc 2018